http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19a4edf953fcd5e6359f550228be65d1
Outgoing Links
Predicate | Object |
---|---|
family-name | Sinilnikova |
name | Olga M Sinilnikova Olga M. Sinilnikova |
given-name | Olga M. Olga M |
organization-name | 98INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.; 102Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon – Centre Léon Bérard, Lyon, France.; 1IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. CRC Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 4RN, United Kingdom; Unit of Genetic Epidemiology, International Agency for Research on Cancer, 69008 Lyon, France; Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom; Department of Human Genetics and Department of Pathology, Leiden University, NL-2333 AA, Leiden, The Netherlands; www.kconfab.org; Westmead Institute for Cancer Research, University of... 1IARC;; 3Plate-forme mixte de génétique constitutionnelle des cancers fréquents, Hospices Civils de Lyon/Centre Léon Bérard; Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France101INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Lyon, France,; Equipe labellisée LIGUE 2008, UMR5201 CNRS, Centre Léon Bérard, Université de Lyon, Lyon, France, 1IARC;; 2Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; “Genetics of Breast Cancer” Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard Lyon France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard Lyon France International Agency for Research on Cancer, 150, cours A. Thomas, 69372 Lyon, France. sinilnikova@iarc.fr Authors' Affiliations: 1Queensland Institute for Medical Research, Brisbane, Australia; 2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care; 3Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 4IARC, Lyon, France; 5University of Pennsylvania School of Medicine; 6Abramson Cancer Center; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; 8Medical University of Vienna, Waehringer Guertel, Vienna, Austria; 9Hereditary Cancer Risk Program at the Baylor-Sammons Cancer Center; 10University of Texas, Southwestern Medical Center, Dallas, Texas; 11Beth Israel Deaconess Medical Center; 12Dana Farber Cancer Institute, Boston, Massachusetts; 13City of Hope, Duarte; 14UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California; 15Creighton University, Omaha, Nebraska; 16Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS; Authors' Affiliations: 1Queensland Institute for Medical Research, Brisbane, Australia; 2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care; 3Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 4IARC, Lyon, France; 5University of Pennsylvania School of Medicine; 6Abramson Cancer Center; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; 8Medical University of Vienna, Waehringer Guertel, Vienna, Austria; 9Hereditary Cancer Risk Program at the Baylor-Sammons Cancer Center; 10University of Texas, Southwestern Medical Center, Dallas, Texas; 11Beth Israel Deaconess Medical Center; 12Dana Farber Cancer Institute, Boston, Massachusetts; 13City of Hope, Duarte; 14UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California; 15Creighton University, Omaha, Nebraska; 16Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Authors' Affiliations: 1Genetics of Breast Cancer Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard; 2Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard; and 3Université Lyon 1, CNRS UMR 5558, Villeurbanne and Centre Léon Bérard, Lyon, France; Authors' Affiliations: 1Genetics of Breast Cancer Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard; 2Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard; and 3Université Lyon 1, CNRS UMR 5558, Villeurbanne and Centre Léon Bérard, Lyon, France INSERM U1052, CNRS UMR5286, Université Lyon 1, Cancer Research Center of Lyon, Lyon, France,; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France, INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France. |
Incoming Links
Total number of triples: 93.